Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer

NEXT STORY
Scopus BioPharma to Present at the LD Micro Main Event
PREV STORY
VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

author_avatar
NASDAQ Market News

ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)

Phase 3 IMPLANT 2 trial results showed Live Birth Rate increased by up to ...

author_avatar
NASDAQ Market News

Nutra Pharma Responds to FDA Warning Letter

author_avatar
NASDAQ Market News